Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)-SLCG 10/02.

被引：2
|
作者：
Provencio, Mariano
de las Penas, Ramon
Insa, Amelia
Martinez-Banaclocha, Natividad
Fabregat, Raquel Marse
Sanchis, Pilar Mut
Moran, Teresa
Sala, Angeles
Massuti, Bartomeu
Ortega, Ana Laura
Jurado, Jose Miguel
Gomez-Codina, Jose
Diz, Pilar
Artal-Cortes, Angel
Calderon, Vanesa Gutierrez
Vazquez, Maria Francisca
Vinolas, Nuria
Quintana, Miguel Angel Munoz
Garcia-Gomez, Ramon
Isla, Dolores
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.8538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8538
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin and chemoradiation in stage III NSCLC. SLCG 10/02.
    Provencio-Pulla, Mariano
    De Las Penas, Ramon
    Banaclocha, Natividad Martinez
    Fabregat, Raquel Marse
    Insa, Amelia
    Moran, Teresa
    Sala Gonzalez, Maria Angeles
    Massuti, Bartomeu
    Mut Sanchis, Pilar
    Ortega Granados, Ana Laura
    Miguel Jurado, Jose
    Gomez-Codina, Jose
    Artal-Cortes, Angel
    Francisca Vazquez, Maria
    Gutierrez Calderon, Vanesa
    Diz, Pilar
    Vinolas, Nuria
    Maestu, Inmaculada
    Camps, Carlos
    Isla, Dolores
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02
    Provencio Pulla, M.
    de las Penas, R.
    Martinez Banaclocha, N.
    MarsE Fabregat, R.
    Insa Molla, A.
    Moran, T.
    Sala Gonzalez, M. A.
    Massuti Sureda, B.
    Mut Sanchis, P.
    Ortega Granados, A. L.
    Jurado, J. M.
    Gomez Codina, J.
    Artal-Cortes, A.
    Vazquez, F.
    Gutierrez Calderon, V.
    Diz Tain, P.
    Vinolas Segarra, N.
    Maestu Maiques, I.
    Camps, C.
    Isla Casado, M. D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Efficacy RENO Study Results of Oral Vinorelbine or Etoposide with Cisplatin Et Chemo-Radiation in Stage III NSCLC. SLCG 10/02
    Isla, Dolores
    De las Penas, Ramon
    Marse, Raquel
    Insa Molla, Amelia
    Martinez-Banaclocha, Natividad
    Moran, Teresa
    Mut, Pilar
    Angeles Sala, Maria
    Massuti, Bartomeu
    Ortega Granados, Ana Laura
    Miguel Jurado, Jose
    Artal Cortes, Miguel
    Vazquez, Maria
    Gutierrez, Vanesa
    Diz Tain, Pilar
    Gomez-Codina, Jose
    Maestu Maiques, Inma
    Camps, Carlos
    Vinolas Segarra, Nuria
    Ponce Aix, Santiago
    De Mon Soto, Melchor Alvarez
    Garcia Gomez, Ramon
    Provencio, Mariano
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S373 - S374
  • [4] NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).
    Isla, Dolores
    Majem, Margarita
    Guirado, Maria
    Massuti, Bartomeu
    De Las Penas, Ramon
    Granados, Ana Laura Ortega
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
    Guirado, M.
    Majem, M.
    Massuti Sureda, B.
    de las Penas Bataller, R.
    Ortega Granados, A. L.
    Isla Casado, M. D.
    Domine Gomez, M.
    Marse Fabregat, R.
    Sala, M. A.
    Paredes Lario, A.
    Moran Bueno, M. T.
    Vazquez Estevez, S.
    Coves Sarto, J.
    Gonzalez-Larriba, J. L.
    Sanchez Torres, J. M.
    Vicente, D.
    Farre Bernado, N.
    Fernandez-Fornos, L.
    Varcarcel, F.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 594 - 594
  • [6] Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02)
    Majem Tarruella, M.
    Isla Casado, L.
    Guirado, M.
    Massuti Sureda, B.
    Ortega Granados, A. L.
    Marse Fabregat, R.
    Domine Gomez, M.
    de las Penas, R.
    Moran Bueno, M. T.
    Vazquez Estevez, S.
    Sala Gonzalez, M. A.
    Coves Sarto, J.
    Sanchez-Torres, J. M.
    Vicente Baz, D.
    Gonzalez-Larriba, J.
    Paredes, A.
    Farre, N.
    Fernandez Fornos, L.
    Mena, A.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] A randomized phase II trial of concurrent chemo-RT of oral vinorelbine and 60 Gy or 66 Gy, in locally advanced NSCLC
    Hansen, O.
    Knap, M.
    Khalil, A.
    Nyhus, C.
    McCulloch, T.
    Holm, B.
    Brink, C.
    Hoffmann, L.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S122 - S123
  • [8] A phase II study of oral vinorelbine concurrent to thoracic radiotherapy (TRT) in elderly locally advanced (LA) stage NSCLC: Preliminary results
    Silvano, G.
    Lazzari, G.
    Soloperto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Long-Term Survival of Phase II of Full-Dose Oral Vinorelbine Combined with Cisplatin Et Radiotherapy in Locally Advanced NSCLC
    Juan, Oscar
    Vazquez, Sergio
    Casal Rubio, Joaquin
    Luis Firvida, Jose
    Aparists, Francisco
    Munoz, Jose
    Garcia Sanchez, Jose
    Girones, Regina
    Lazaro Quintela, Martin
    Giner, Vicente
    Sanchez Hernandez, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S853 - S853
  • [10] INTERIM ANALYSIS OF THE SPANISH LUNG CANCER GROUP (SLCG) RANDOMIZED PHASE II TRIAL OF THORACIC RADIOTHERAPY (RT) CONCURRENT WITH CISPLATIN (P) PLUS ORAL VINORELBINE (OV) OR ETOPOSIDE (E) FOR UNRESECTABLE LOCALLY ADVANCED (LA) STAGE III NON-SMALL CELL LUNG CANCER (NSCLC). (GECP10/02)
    Isla, Dolores
    De Las Penas, Ramon
    Martinez-Banaclocha, Natividad
    Massuti, Bartomeu
    Angeles Sala, Maria
    Bover, Isabel
    Marse, Raquel
    Insa, Amelia
    Moran, Teresa
    Artal, Angel
    Diz, Pilar
    Gomez-Codina, Jose
    Laura Ortega, Ana
    Gutierrez, Vanesa
    Munoz, Jose
    Alvarez De Mon, Melchor
    Camps, Carlos
    Garcia-Gomez, Ramon
    Jurado, Jose M.
    Ponce-Aix, Santiago
    Provencio, Mariano
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S408 - S408
12345